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Highlights 
 
 We undertook a WHO-commissioned rapid systematic review of evidence to examine 
whether limiting the use of antimicrobials in food animals decreases antimicrobial 
resistance 1) in those food animals; 2) in humans 
 89 studies (3 direct, 86 indirect) provided adequate evidence that limiting antimicrobials 
given to animals reduces antimicrobial resistance in animals; heterogeneity precluded 
estimating the magnitude of effect 
 4 studies (1 direct, 3 indirect) suggested that withdrawing antimicrobials in food animals 
results in decreased antimicrobial resistance in humans 
 The paucity of well-designed primary studies that directly answer these questions 
means these should be urgently commissioned to strengthen the evidence of the 
magnitude of the effect of stopping antimicrobial use in food animals – particularly on 
resistance in the bacterial flora of humans 
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ABSTRACT   
 
Background:  
Large quantities of antimicrobials are given to food animals, especially in feed, potentially 
risking increased antimicrobial resistance in humans. However, the magnitude of this effect 
is unclear.  
 
Methods:  
We searched PubMed, Embase and Web of Science, for studies on interventions which 
limited antimicrobial use in food animals, in any setting and context, to reduce antimicrobial 
resistance 1) in those food animals; and 2) in humans. We validated our strategy by testing 
whether it identifies known relevant studies. Data from included studies were extracted into 
pre-designed and pilot-tested forms.  
 
Results:  
We included 104 articles containing 93 studies. Heterogeneity (from different animal species, 
environs, antimicrobial classes, interventions, administration routes, sampling, and methods), 
was considerable, precluding meta-analysis. The evidence was therefore synthesised 
narratively. 89 studies (3 directly, 86 indirectly) addressed the question whether limiting 
antimicrobial exposure in food animals led to decreased antimicrobial resistance in those 
animals. The evidence was adequate to conclude this, although the magnitude of the effect 
could not be quantified; 4 studies (1 directly, 3 indirectly) examined the question of whether 
withdrawal of antibiotics changed resistance of potential pathogens in retail food for human 
consumption, and in bacteria of humans themselves. The direct (observational) study of 
broiler hatchery in ovo antimicrobial injection found a credible effect in terms of size 
reduction and time sequences.    
 
Interpretation:  
Limiting antimicrobial use in food animals reduces antimicrobial resistance in food animals, 
and probably reduces antimicrobial resistance in humans. The magnitude of the effect 
cannot be quantified. 
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BODY TEXT  
 
1. Background 
Large quantities of antimicrobials – including those within the same class as human 
therapeutic drugs – are administered to food animals, to treat and prevent bacterial diseases 
in animals but also in some cases to promote growth.[1-4] The practice of antimicrobial use 
generates resistance which potentially threatens both human and animal health, with 
devastating downstream economic consequences.[1, 2]  The World Health Organisation 
(WHO) reports on health consequences of foodborne diseases,[5] but not the human health 
burden from antimicrobial-resistant disease associated with antimicrobial use in food animals.  
 
There is a long history of public health concern about antimicrobial use in food animals. The 
United Kingdom‟s Netherthorpe Committee in 1960 investigated whether it constituted a 
danger to humans. The Swann Committee in 1969 concluded that it does,[6] and 
subsequently many scientific, regulatory, and professional organisations elsewhere have 
expressed concern. A new wave of concern arose in the 1990s with the registration of 
fluoroquinolones and third-generation cephalosporins for therapeutic use in food animals. 
This led to a WHO Consultation on Medical Impact of the Use of Antimicrobials in Food 
Animals, which concluded that use of antimicrobials in food animals can lead to antimicrobial 
resistance in humans, particularly in foodborne pathogens such as Salmonella and 
Campylobacter, despite considerable uncertainty about the magnitude of the effect.[7]  
 
Responding to current calls for guidelines to preserve the long-term effectiveness of 
antimicrobials critically important for human medicine, the WHO commissioned two 
systematic reviews of the evidence, which addressed the following two questions: whether a 
limitation on the use of antimicrobial agents in food animals reduced the presence of 
antimicrobial-resistant genetic elements or antimicrobial resistant bacteria (1) in food animals; 
and (2) in humans.  
 
Two groups were selected to conduct the systematic reviews simultaneously, albeit 
independently of each other. We present our findings as one of the two groups[8] awarded 
funding. The WHO Guideline on the use of medically important antimicrobials in food 
animals – which was informed by these systematic reviews – was published recently.[9]  
 
2. Material and methods  
We undertook a rapid systematic review to meet deadlines required by the WHO guidelines 
development timetable, in accordance with a pre-existing protocol and using accepted 
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methods.[10-12] This required us to deploy 10 staff with expertise in systematic reviewing, 
information retrieval, antimicrobial use in humans and animals, and biostatistics.  
 
A set of potentially relevant studies was built from several sources: 1) forward and backward 
citation searches on one relevant reference for each question;[13, 14] 2) an updated search 
of a recent relevant report on the subject;[1] and 3) known relevant studies provided by the 
WHO Group developing the guideline at our request. The resulting set consisted of 26 
articles spanning the period from 1976 to 2016, which we labelled a „validation set‟ 
(Appendix A). The common key words of the studies comprising the validation set were then 
used to build two searches: one search for the animal question, and one search for the 
human question. These search strategies were tested in PubMed, to verify that all of the 
articles in the validation set were found by the strategy. These final search strategies were 
run on 10 June 2016 without language or date restrictions, and were modified appropriately 
to search Embase and Web of Science. Full search strategies are presented in Appendix B. 
 
We scoped the volume and quality of the evidence through an examination of the first 100 
references found by the searches. The examination suggested that both greater volume and 
higher quality evidence will be found for the question addressing antimicrobial resistance in 
animals. Accordingly, we included only the study designs of higher quality and less prone to 
bias for the animal question, and relaxed the rigour by additionally including interrupted time 
series and before and after designs for the human question. 
 
The inclusion and exclusion criteria were as follows: 
 
Animal question:  
 Inclusion: Studies addressing the question; study designs that were probable or 
certain to be: reviews (systematic, literature), RCTs, challenge trials, controlled 
trials, or cohort studies; published in any language and on any date 
 Exclusion: studies that were certain or probable to be: case-control, interrupted 
time series, before and after, cross-sectional, ecological, case series. 
 
Human question:  
 Inclusion: Studies addressing the question; studies that were probable or certain 
to be: reviews (systematic, literature), RCTs, challenge trials, controlled trials, 
cohort studies, case-control, interrupted  time series, before and after; published 
in any language and on any date 
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 Exclusion: studies that were certain or probable to be: cross-sectional, ecological, 
case series.  
 
No restriction on the basis of ready accessibility of literature was used.  
 
The literature search was supplemented in three ways: 1) the WHO Guidelines Group and 
the content experts on our team provided key known relevant references; 2) a forward (citing 
articles) citation search was done in Web of Science on a key identified study on the effect in 
humans[15] to identify studies that have subsequently cited that study; and 3) the references 
of a study comparing the impact of stopping antimicrobials to continuing antimicrobials in 
food animals[16] was hand searched. There was insufficient time to contact study authors 
directly, or systematically search the grey literature, although where we found grey literature, 
we considered it against inclusion/exclusion criteria.  
 
Ideally, in systematic reviews, two or more authors screen titles and abstracts for 
inclusion,[17] but time constraints in rapid systematic reviews mean this is frequently 
foreshortened to a single reviewer.[12] We adopted a compromise: the entire set of 
references was screened by a single author, but a second author screened a random 
sample of 10% references. The two authors subsequently met to resolve discrepancies.  
Included references were then reviewed in full-text by pairs of authors working independently, 
with discrepancies resolved by discussion or by a third reviewer if necessary. Data from 
included studies were extracted using pre-piloted data extraction forms (Summary of 
Findings, and Table of Included Studies), and checked by a second author.  
 
The following information was extracted from studies into a Table of Included Studies form: 
study location and date; species and number studied; comparison (e.g. antimicrobial vs no 
antimicrobial, antimicrobial vs lower dose, etc.); study design; sampling (setting, approach, 
proportion of subjects sampled, duration, frequency); exposure (antimicrobial, dose, duration, 
frequency); comparator (type, does, duration, frequency); and unit of measurement (e.g. 
prevalence of resistance, odds ratios, etc.) The Summary of Findings form collected the 
following information: study author and date; exposed and unexposed animal species; 
exposed and unexposed humans (professional category if applicable); method of measuring 
resistance; and prevalence of resistance prior, during and after exposure.    
  
The considerable heterogeneity of the included studies precluded formal assessment for risk 
of bias and meta-analysis. Instead, we categorised the included studies by study-design, 
using a hierarchy of evidence specifically devised for animal studies, and described the 
results narratively.  
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3. Results 
 
Database searches yielded 7,023 references, and supplementary search strategies yielded 
an additional 132 references. After amalgamation and de-duplication of the two sets of 
references, 3,709 references remained (Figure A.1). The 3,709 references were title/abstract 
screened by a single author, and a second author screened a random sample of 10% 
(n=371) references. Title/abstract screening involved checking the titles and abstracts of 
identified references against the inclusion and exclusion criteria. Those references whose 
titles and abstracts appeared to meet the inclusion criteria were included; if it was uncertain 
whether a reference met the inclusion criteria, we included it. Resolution of discrepancies in 
the two authors‟ decisions about inclusions and exclusions of references resulted in an 
inclusion of 9 previously excluded references.  At this stage, 210 references were advanced 
to full-text screening. Full-text screening against the inclusion and exclusion criteria was 
conducted by pairs of authors working independently, with discrepancies resolved by 
discussion or by a third reviewer if necessary; 106 references were excluded, leaving 104 
(Figure A.1) to be data-extracted.  
 
3.1 Interventions influencing resistance in bacteria in animals  
 
There were 89 studies in 97 publications relevant to answering the animal question: 24 (27%) 
were randomised controlled trials (RCTs) conducted under field conditions, considered a 
higher level of evidence than the other study designs (Figure A.2). The remainder of the 
studies were: other types of controlled trials and challenge studies (n=46); cohort studies 
(n=17); and interrupted time series (ITS) (n=2) (both of which were found by hand searching, 
although this study-type was not initially included). No studies meeting the inclusion criteria 
were systematic or literature reviews.  
 
The most commonly studied animals were pigs (28 studies, including 7 RCTs, 13 other 
controlled trials and challenge studies, 7 cohort studies, 1 ITS) and cattle/steers/calves (28 
studies, including 12 RCTs, 13 other controlled trials and challenge studies, 3 cohort). Other 
animals studied were chickens (23 studies, including 5 RCTs, 14 other controlled trials, 3 
cohort studies, and 1 ITS) and turkeys, lambs, sheep, fish, and mixed (3 studies or fewer 
each).  
 
Of the 89 included studies, 3 directly answered the question whether a limitation on the use 
of antimicrobial agents in food animals reduced the presence of antimicrobial-resistant 
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genetic elements or antimicrobial resistant bacteria in food animals; 86 studies answered the 
question indirectly. The studies directly answering the question included: an RCT which 
compared the impact of continuing exposure to oxytetracycline and neomycin versus 
withdrawal,[18] and two ITS studies comparing the resistance to tetracyclines before and 
after their withdrawal in the United Kingdom,[19] and the resistance to cephalosporin before 
and after the withdrawal of ceftiofur in Japan.[20]   
 
Among the remainder of the included studies, the common comparisons were antimicrobial 
versus no antimicrobial, evaluated by 67 studies (22 RCTs, 32 other controlled trials and 
challenge studies, and 13 cohort studies). Other studies compared various doses and/or 
durations of antimicrobials. Some comparisons were also conducted as part of „challenge 
trials‟, in which animals were artificially infected (“challenged”) with bacteria carrying genetic 
material known to promote resistance. Some studies compared animals given an 
antimicrobial with those not given an antimicrobial, with the groups kept in isolation from one 
another, whereas other studies kept both groups together, and assessed transfer of 
resistance from animals that received antimicrobials to those that did not.  
 
A wide range of antimicrobials or their combinations were studied. Among the 24 RCTs 
alone, 21 different antimicrobials or their combinations were studied. The only antimicrobials 
considered by more than one study (of any design), were: ceftiofur, an antimicrobial that can 
only be administered to animals by injection (6 studies), chlortetracycline, available in both 
oral and parenteral forms (9 studies); enrofloxacin, injection and water medication only (3); 
oxytetracycline and neomycin, oral and parenteral forms (2 studies); oxytetracycline (4 
studies); tetracycline (3 studies); tylosin, oral and parenteral forms (6 studies); and 
virginiamycin, oral only (2 studies).  
 
Studies also used a variety of methods to measure and quantify outcomes. 51 (57%) of the 
89 animal studies used microbial culture for phenotypic assessment only, 11 (12%) PCR 
determination, 26 (29%) both methods, and one study did not report the method used. The 
comparison of resistance levels between groups was expressed as the proportion of isolates 
with resistance, or absolute counts of resistant isolates, or both.  
 
In summary, the study aims and designs varied widely, with considerable heterogeneity in 
terms of antimicrobials, bacteria selected for challenge, or resistance measurement, animals, 
methods for measuring resistance, sampling timeframes, and methodology amongst studies. 
This precluded the possibility of a meta-analysis. However, a summary of results is 
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presented in Table A.1; more detailed results are presented in Appendix C and full 
references for all of the included studies are provided in Appendix D.  
  
 
[insert table A.1 here] 
 
Table A.1 utilises WHO‟s categorisation of antimicrobials that are important for human 
medicine into: Critically Important, Highly Important, and Important.[21] A further category – 
„other‟ – is added to the table, to indicate studies that evaluated antimicrobials not on the 
WHO list.  
 
In Table A.1, each study‟s result was coded in the following manner: black indicates that the 
study found higher resistance in bacteria isolated from animals exposed to more 
antimicrobial (e.g. higher resistance found in animals exposed to antimicrobials, than in 
animals not exposed to antimicrobials; or in animals exposed to a higher dose of 
antimicrobials than in animals exposed to a lower dose). Light grey indicate the opposite – 
that a lower resistance was found in animals exposed to more antimicrobial, or that lower 
resistance was found in animals exposed to antimicrobial than in animals unexposed. Finally, 
criss-crossed pattern indicates that the study found mixed results – e.g. animals exposed to 
more antimicrobials initially showed higher resistance but subsequently showed lower 
resistance than animals exposed to less antimicrobials, or that exposed animals showed 
higher resistance to one antimicrobial but lower resistance to another antimicrobial.  
 
Studies addressing the animal question directly suggest that a limitation of antimicrobials in 
food animals leads to a decrease in resistance to antimicrobials in those animals. One RCT 
examined the impact of discontinuation of feeding dairy calves with milk replacer containing 
oxytetracycline and neomycin, compared to its continuation. It found that the discontinuation 
was significantly associated with increased susceptibility to tetracyclines in both E. coli and 
Salmonella, with the effect most pronounced in the first 3 months.[18] An ITS study 
examined the impact of the United Kingdom‟s 1971 ban on the use of tetracyclines in pigs to 
promote growth. It showed that prior to the ban, the percentage of samples with tetracycline 
resistance increased from 18% (in 1956) to 64% (in 1970). The prevalence of resistance 
decreased to 23-41% 2-5 years after the ban.[19] Another interrupted time series study 
examined the impact of voluntary withdrawal, in March 2012, of off-label use of ceftiofur in 
chicken hatcheries in Japan. The study examined the impact on the prevalence of resistance 
to a broad-spectrum cephalosporin in E coli isolates from healthy broilers, and found a 
decrease from 16.4% resistance in 2010 to 4.6% resistance in 2013 (p=0.001).[20] 
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The majority of the studies addressing the question indirectly, showed that exposing animals 
to antimicrobials results in higher resistance to those antimicrobials, than exposing animals 
to no (or a lower dose) of those antimicrobials. This result is consistent across included 
study types – RCT conducted under field conditions, other controlled trial types and 
challenge studies, cohort study, and interrupted time series. The result also holds regardless 
of the WHO classification of importance to human health – critical, highly important or 
important. The majority of RCTs and other controlled and challenge studies focused on 
evaluating antimicrobials that are categorised as „critically important‟ or „highly important‟ to 
human health; very few studies evaluated antimicrobials classified as „important.‟   
 
3.2 Interventions influencing resistance in bacteria in humans  
 
We identified only one study which directly addressed the question of whether stopping the 
use of antimicrobials in food animals resulted in reduced antimicrobial resistance in bacteria 
in humans – the original question asked by the WHO committee.[15] The study reported 
data from Quebec, Canada, where injections of ceftiofur – a third generation cephalosporin – 
into eggs in chicken hatcheries was voluntarily withdrawn in 2005, and then partially 
reintroduced in 2007. The study measured the prevalence of resistance in Salmonella 
enterica serovar Heidelberg isolated from both retail chicken carcasses and clinical samples 
from infected humans across Canada, as well as E. coli samples (chickens only). The study 
found that the withdrawal of in ovo antimicrobial use in chickens was associated with a 
reduction in resistance in both bacterial species isolated from chicken meat for human 
consumption, and in clinical samples from infected humans (Figure A.3). Re-introduction of 
the in ovo antimicrobial use was similarly associated with an increase in resistance in both 
cohorts. The temporal pattern of changes in resistance was consistent with a causal effect. 
The findings of this study are expanded with national-level data from Canada, reported by 
the Public Health Agency of Canada[22]  and the Canadian Integrated Program for 
Antimicrobial Resistance Surveillance[23] (Figure A.4)  
 
Additionally, three studies addressed the human question indirectly – that is, they examined 
whether the introduction of antimicrobials was associated with increased resistance in 
animals and humans.[24-26]  A cohort study of pigs and human farm residents, conducted in 
the Netherlands, found a significant dose-response relationship (across all farms) between 
the dose of antimicrobial and multi-antimicrobial-resistant livestock associated methicillin-
resistant Staphylococcus aureus (LA-MRSA): 16% increase in odds for a doubling of dose in 
pigs, and 1.2% increase in odds for a doubling of dose in humans.[24] A second study 
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reported resistance monitoring data among poultry in the United States, reporting that the 
odds ratio for resistance in human Campylobacter clinical isolates was 2.5 for the presence 
of resistance after fluoroquinolones were introduced for food animal use in 1995-6, 
compared to prior to introduction.[25] Similar findings from Spain showed that after 
fluoroquinolones were introduced for food animal use, there was an increase in prevalence 
of resistance in the  human Campylobacter clinical isolates (general population) from a 
baseline of approximately 10% to >80%.[26, 27] In both reports of an increasing trend of 
fluoroquinolone resistance prevalence in Campylobacter it was not possible to apportion the 
relative contributions of human and animal use of the concurrently used fluoroquinolones. 
 
4. Discussion  
Our rapid systematic review examined whether a limitation on the use of antimicrobial 
agents in food animals reduced antimicrobial resistance in those food animals and in 
humans. The majority of studies addressed the question indirectly – that is, they examined 
whether an increase in exposure to antimicrobials increases resistance. Three (3) studies 
directly addressed the animal question, suggesting that a limitation of antimicrobial exposure 
in food animals leads to a decrease in resistance to antimicrobials in particular bacterial 
species in those animals, however the magnitude of the effect cannot be quantified. A single 
study – of injectable antimicrobial use – provided evidence to directly address the human 
question. It concluded that limiting in ovo antimicrobial exposure in broiler chickens reduced 
the burden of antimicrobial resistance in the animals themselves as well as in contact 
humans and consumers.[15] The size of the effect is large enough to make this study 
credible. Moreover, the time-courses are also credible for this to be a causal association. 
However, the overall body of evidence – consisting of a single study, of observational design 
– for the human question is thin, and on this basis, it is not possible to quantify the effect. 
Moreover, the effect is probably specific to the use of a critically important antimicrobial for 
routine injection into eggs to prevent E. coli infection (this is not an established practice in 
most poultry producing countries) and may differ for each antimicrobial, dosage, route of 
administration, infection type, food animal species and management system and 
environment.  
 
The review has a few limitations. First, it is limited by a paucity of well-conducted primary 
studies that directly addressed the questions – only 3 studies (one RCT and two interrupted 
time series) directly addressed the animal question, and 1 study (an interrupted time series) 
directly addressed the human question. The majority of the included studies (86 studies of 
animals, and 3 studies of humans) addressed the questions only indirectly, by examining the 
impact of an increase in antimicrobial exposure (e.g. greater duration, higher dose, 
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increased frequency) compared to its decrease (no antimicrobial, shorter duration of 
exposure, lower dose or decreased frequency). The majority of the studies showed that 
increased exposure to antimicrobials leads to increased resistance – or conversely, that a 
lower exposure is associated with lower resistance. The paucity of well-designed primary 
studies that directly address these questions means these studies should be urgently 
commissioned to strengthen the evidence of the magnitude of the effect of stopping 
antimicrobial use in food animals – particularly on resistance in bacteria in humans. 
 
Second, the conduct and reporting of the included studies were highly heterogeneous: there 
was a wide range of animal species studied; whether resistance was measured in index 
animals alone or in others to which resistance might have been transmitted; a variety of 
micro-organisms used to assess resistance (some of which are pathogens to humans); 
antimicrobial drugs investigated (with some „critical for human use‟); the purpose of 
antimicrobial use (as growth promoters or for prophylaxis to a whole population or to treat 
individually sick animals); and measures of resistance (most using bacterial culture 
susceptibility testing, while a minority used individual resistance gene detection by PCR). 
Reporting methods were also difficult to compare, as some studies reported the difference 
between exposed and unexposed groups as the proportion of individuals with resistance, 
some as the proportion of samples with resistance (which may include multiple samples per 
individual) and some as the proportion of resistant isolates (which may include multiple 
isolates per sample, or per individual). A systematic review commissioned by the WHO to be 
conducted in parallel with the present one, found statistical heterogeneity of this evidence to 
be greater than 90%.[8] Since we do not know the distribution of resistance in multiple 
samples or isolates from the same individual, these measurements cannot be combined in 
meta-analysis with those from studies concerning measures in individuals, we considered it 
inappropriate to undertake meta-analysis. Instead we summarise the data descriptively 
without a summary estimate as a pragmatic and less misleading approach.[17] 
 
The finding that use of one antimicrobial can result in selection for resistance to a different 
antimicrobial class,[18, 28, 29] and the apparent spontaneous appearance of resistance 
without any direct exposure to the implicated antimicrobial,[18, 29-32] may have a number of 
causes and may represent an un-observed exposure to the drug, a spontaneous horizontal 
transfer of genes on integrative conjugative elements (ICEs), or activation of associated 
genes. If the latter, the implication is that use of one antimicrobial may carry potential 
problems for other antimicrobials, particularly if co-selection is occurring favouring 
acquisition and maintenance of multidrug-resistant plasmids, transposons or other 
integrative conjugative elements. Furthermore the role of other potential co-selective agents 
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such as biocides and heavy metals (e.g. copper, zinc) requires further investigation,[33-35] 
particularly where they are used as replacements for traditional antimicrobials in food 
animals for growth promotion and/or therapeutic or prophylactic purposes.[36, 37] 
 
5. Conclusion 
 
Despite the paucity of evidence, it seems biologically plausible to conclude that the use of 
antimicrobials in animals can result in the selection and dissemination of antimicrobial 
resistance determinants to bacteria in other food animals, including their carcasses and 
meat for human consumption, and to humans themselves. More primary studies are required 
to strengthen the research evidence, a conclusion also reached recently by the Food and 
Agriculture Organisation of the United Nations.[38] Importantly, several countries (e.g. 
Canada CIPARS, Denmark DANMAP; United States NARMS) now have comprehensive and 
well-established surveillance and reporting systems for monitoring antimicrobial resistance in 
food, animal and human pathogens and food animal commensals, as well as antimicrobial 
use in both human and veterinary sectors. These and emerging programmes in other 
countries, will allow for more integrative studies to correlate resistance levels with 
antimicrobial use and can be expected to provide substantial insights and evidence in 
answering important questions to guide antimicrobial risk management options. Such 
programmes are also critical to maintain the longevity of currently registered shared drug 
classes, as new human-only and animal-only drug classes are developed. 
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Figure A.1: PRISMA[39] Flow Diagram 
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Figure A.2: Hierarchy of evidence for animal studies (modified from original) in Sergeant 2014 [40] 
 
Figure A.3: Resistance to ceftiofur over time in Quebec, Canada (redrawn from data in Dutil 2010[15]) 
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Figure A.4: Resistance to ceftiofur over time in Canada (redrawn from data in Public Health Agency of Canada [22] and Canadian 
Integrated Program for Antimicrobial Resistance Surveillance [23] 
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Table A.1: Resistance to antibiotics important to human health: studies comparing animals exposed to (more) antibiotics, and 
animals exposed to no/less of those antibiotics. 
 
Study type Reference* Isolate 
Resistance to antibiotics important to human 
medicine 
Critically 
Important 
Antibiotics 
Highly 
Important 
Antibiotics 
Important 
Antibiotics 
Other 
Antibiotics 
R
C
T
s 
u
n
d
er
 f
ie
ld
 c
o
n
d
it
io
n
s 
Usui 2014 Campylobacter         
Amachawadi 2015 Enterococcus         
Beyer 2015 Escherichia     
da Costa 2008, 2009, 2010 Various         
Le Devendec 2015  Various         
Kanwar 2013, 2014 Escherichia       
Pereira 2014  Escherichia       
Kaneene 2008  Various       
Wagner 2008  Various       
Chen 2008  Various         
Davies 1999 Enterococcus         
McDermott 2005 Enterococcus         
Agga 2014, 2015 Escherichia         
Checkley 2010 Escherichia         
Delsol 2003  Various         
Edrington 2014  Various         
Platt 2008  Various         
Alexander 2008, Mirzaagha 2011 Escherichia         
Butaye 2005 Enterococcus         
Chambers 2015  Various         
Olumeyan 1986  Various         
Study type Reference Isolate 
Resistance to antibiotics important to human 
medicine 
Critically 
Important 
Antibiotics 
Highly 
Important 
Antibiotics 
Important 
Antibiotics 
Other 
Antibiotics 
O
th
er
 c
o
n
tr
o
lle
d
 t
ri
al
s 
an
d
 c
h
al
le
n
g
e 
st
u
d
ie
s 
Farnell 2005 Campylobacter         
Ladely 2007  Campylobacter         
Lin 2007  Campylobacter         
Logue 2010  Campylobacter         
Stapleton 2010  Campylobacter         
Takahashi 2005  Campylobacter XXXXXXX       
Cameron-Veas 2015  Escherichia      
Cavaco 2008  Escherichia      
Herrero-Fresno 2016  Escherichia      
Huang 2014  Escherichia      
Jimenez-Belenguer 2016  Escherichia      
Jiang 2006  Salmonella      
Aarestrup 1998  Various      
Alali 2009b  Various      
Daniels 2009  Various      
Zaheer 2013  Various      
van der Horst 2013  Escherichia      
Alali 2004  Escherichia       
Berge 2006 Escherichia       
Kim 2005  Escherichia         
Ebner 2000  Salmonella         
Johnson 2015 Escherichia       
Khachatryan 2004  Escherichia   XXXXXXX   
Khachatryan 2006  Escherichia       
Kobe 1995  Escherichia       
Bauer-Garland 2006 Salmonella       
DeGeeter 1976  Salmonella       
Evangelisti 1975 Salmonella       
Funk 2006  Salmonella       
Moodley 2011  Staphylococcus       
Molitoris 1986  Streptococcus   XXXXXXX   
Finlayson 1973 Various       
Wierup 1975  Escherichia     
Alexander 2010; Beukers 2015  Escherichia         
Sharma 2008, Wu 2011  Escherichia         
Inglis 2005  Various      
Kobe 1996  Escherichia      
Cassenego 2011  Enterococcus         
Brunton 2014  Escherichia         
Benazet 1980 Salmonella         
Delsol 2005  Various         
Edrington 2003  Various         
Kempf 2013  Various        
Study type Reference Isolate 
Resistance to antibiotics important to human 
medicine 
Critically 
Important 
Antibiotics 
Highly 
Important 
Antibiotics 
Important 
Antibiotics 
Other 
Antibiotics 
C
o
h
o
rt
 s
tu
d
ie
s 
Juntunen 2010  Campylobacter     
Heuer 2002a  Enterococci          
Andersen 2015  Escherichia     
Baron 2014  Escherichia     
Callens 2015  Escherichia      
Sato 2004  Campylobacter          
Petersen 2002  Acinetobacter          
Akwar 2008  Escherichia         
Benedict 2015  Escherichia         
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Duse 2015  Escherichia         
Mathew 1999  Escherichia         
Morley 2011  Escherichia       XXXXXXXXX 
Alali 2010b  Salmonella         
Keelara 2013; Quintana-Hayashi 2012  Salmonella         
Rajala-Schultz 2009  Staphylococci         
Nulsen 2008  Various         
Scott 2012  Various       XXXXXXXXX 
Study type Reference Isolate 
Resistance to antibiotics important to human 
medicine 
Critically 
Important 
Antibiotics 
Highly 
Important 
Antibiotics 
Important 
Antibiotics 
Other 
Antibiotics 
IT
S
 
Hiki 2015  Escherichia         
Smith 1975   Escherichia         
 
*References to these studies are provided in Appendix D 
 
 
 
Legend:  
Antibiotics to which resistance is measured by each study are classified using WHO’s taxonomy of antibiotics important for human medicine: 
Critically Important, Highly Important, Important [92]. ‘Other’ category indicates that a study evaluated resistance to antibiotic not on the WHO list. 
 
Coding scheme: 
 Higher resistance in animals exposed to more antibiotic, than those exposed to less antibiotic. 
XXX 
Mixed results (e.g. animals exposed to more antibiotic had more resistance initially but less resistance 
subsequently, than animals exposed to less antibiotic).  
 Lower resistance in animals exposed to less antibiotic, than those exposed to more antibiotic  
 
 
